Tram Tran - 09 Nov 2021 Form 4 Insider Report for Arbutus Biopharma Corp (ABUS)

Role
Director
Signature
/s/ David C. Hastings as attorney-in-fact for Tram Tran
Issuer symbol
ABUS
Transactions as of
09 Nov 2021
Net transactions value
$0
Form type
4
Filing time
12 Nov 2021, 05:22:08 UTC
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABUS Stock Option (Right to Buy) Award $0 +44,000 $0.000000 44,000 09 Nov 2021 Common Shares 44,000 $3.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on November 9, 2021, the date of the grant.
F2 The option will vest and become exercisable in three equal annual installments beginning one year from the grant date.